Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Research Reports

Automated External Defibrillators Market to Rise at CAGR of 11% to Reach USD 48.26 Billion by 2032

Published by Wanda Rich

Posted on April 23, 2025

Featured image for article about Research Reports

The global automated external defibrillators market is expected to grow significantly. For the forecast period 2022-2032, a whopping CAGR of 11% is predicted, reaching US$ 48.26 billion. Technological advancements, as well as increased government involvement through research funding, will drive up demand for automated external defibrillators.

According to the World Journal of Cardiovascular Diseases, approximately 20% of the Western population suffers from cardiac problems. This is due to an increase in obesity, diabetes, smoking habits, high cholesterol, and sedentary lifestyles.

As a result, hospitals are increasingly looking for ways to resuscitate patients suffering from sudden cardiac arrests and ensure rapid response via defibrillators in order to avoid fatalities. Funding for research and development of novel medical technologies that address cardiac emergencies is increasing.

For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=4640

Key Takeaways from the Market Study

Global market for automated external defibrillators to flourish nearly 3x by 2032
U.S to be a highly opportunistic market, registering a CAGR of 8% through 2032
China to be the 2nd most lucrative automated external defibrillator market, growing at a 7.7% CAGR
Japan & South Korea to collectively expand at a CAGR of 12.3% through 2032
Fully-automated defibrillators to expand at a CAGR of 7.3% from 2022-2032

"The global market for automated external defibrillators is expected to grow in the future. Increased government support in the form of research funding for cardiac issues will drive market growth. Key companies are focusing on developing new devices with cutting-edge technology to address heart-related issues," says a Fact.MR analyst.

Leading Players Driving Innovation in the Automated External Defibrillators Market

Koninklijke Philips; Physio-Control Inc. (Stryker); Nihon Koden Corporation; Asahi Kasei Medical Co. Ltd; GE Healthcare Ltd.

Country-wise Analysis

The United States will lead the global market for automated external defibrillators. The increasing incidence of sudden cardiac arrests is given as a key reason for the large market share. During the forecast period, the availability of automated external defibrillators is likely to increase market share. In addition, growing government intervention in promoting greater use of automated external defibrillators is likely to drive market growth. From 2022 to 2032, the CAGR is forecasted to be 8%.

China holds vast growth potential in the future. A growing population, as a result of which there will be a rise in cardiovascular diseases, is expected to propel market growth. In the forecasted period, an impressive growth of 7.7% is projected.

CompetitiveLandscape

With a highly consolidated market, the key players in automated external defibrillators are primarily focused on developing new products. Philips Healthcare, for example, manufactures the HearStart ranges of devices such as the FR3, OnSite, and FRx. Because of their sturdy construction and light weight, these devices are easy to use. Similarly, Stryker manufactures the HeartSine Samaritan PAD 350P, HeartSine Samaritan PAD 360P, LIFEPAK 100 Defibrillator, and LIFEPAK CR Plus devices. The PAD series includes a programme manager that alerts users to potential malfunctions that may impair device performance.

Get Customization on this Report for Specific Research Solutions-
https://www.factmr.com/connectus/sample?flag=S&rep_id=4640

More Valuable Insights

Fact.MR, in its new report, offers an unbiased analysis of the global automated external defibrillators market, analyzing historical demand from 2015-2021 and forecast statistics for 2022–2032.

The study reveals growth projections on the automated external defibrillators market on the basis of key technologies (semi-automatic and fully-automatic), key sizes (standard automated external defibrillators and pediatric automated external defibrillators) and end users (hospitals, public access, emergency medical services, homes, work spaces and private cardiac clinics) across five major regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

Check out More Related Studies Published by Fact.MR:

Trauma Care Centers Market is projected to grow from USD 16.2 billion in 2024 to USD 36.7 billion by 2035, at a CAGR of 7.7%.

Surgical Headlights Market will rise from US$ 1.9 billion in 2022 to US$ 2.4 billion by 2027, growing at a CAGR of 5%.

Hemostasis Diagnostics Market is expected to double from US$ 2 billion in 2020 to over US$ 4 billion by 2031, at a CAGR of 7%; point-of-care testing systems will grow at 5% CAGR.

Blood Cancer Diagnostics Market is forecast to grow from US$ 15.05 billion in 2021 to US$ 28.57 billion by 2032, registering a CAGR of 6%.

NGS Sample Preparation Market will expand from US$ 3.8 billion in 2021 to US$ 8.5 billion by 2032, with a CAGR of 7.3%.

Antibody Drug Conjugate Contract Market is expected to rise from US$ 9.2 billion in 2022 to US$ 38.8 billion by 2032, at a CAGR of 15.5%.

Manual Resuscitators Market is projected to grow from US$ 400 million to US$ 780 million between 2022 and 2032, at a CAGR of 7%.

Point of Care Diagnostics Market is set to grow from US$ 34.1 billion in 2020 to US$ 66 billion by 2028, with a CAGR of 7%.